Anebulo Pharmaceuticals Inc increased I. Quarter net loss per share of $-0.11 compare to net loss per share of $-0.07 recorded in the same quarter a year ago a decrease compare to $-0.05 realized in previous quarter.
I. Quarter
Earnings Per Share
Revenues
$ -0.11
$
0 Mill
$-0.04
Unch.
Anebulo Pharmaceuticals Inc's Revenue
fell by
0 % in I. Quarter (Sep 30 2022) year on year,
to $0 million and
declined by
sequentially.
Anebulo Pharmaceuticals Inc is Expected to report next financial results on February 10, 2023.
Anebulo Pharmaceuticals Inc's
in I. Quarter recorded net loss of $-2.612 million, an increase from net loss of $-1.553 million in I. Quarter a year ago.
